Royal Bank of Canada
ZBH icon

Royal Bank of Canada’s Zimmer Biomet ZBH Stock Holding History

Royal Bank of Canada’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-26,100
Closed -$3.18M – 7687
2023
Q4 		$3.18M Buy
+26,100
New +$2.91M ﹤0.01% 2649

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royal Bank of Canada's ZBH Position: Q1 2026 in Review

Royal Bank of Canada reduced its Zimmer Biomet (ZBH) stake by 21% in Q1 2026, selling an estimated $7.97M and leaving 319,726 shares worth $28.9M. The position accounts for 0.01% of the portfolio, ranked #1208.

Royal Bank of Canada first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $139M in Q3 2025. 914 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Royal Bank of Canada held 319,726 shares of Zimmer Biomet worth $28.9M as of Q1 2026.
  • Royal Bank of Canada sold 86,837 Zimmer Biomet shares in Q1 2026, an estimated $7.97M.
  • Zimmer Biomet made up 0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #1208 holding.
  • Royal Bank of Canada first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Zimmer Biomet position peaked at $139M in Q3 2025.
  • 914 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.